WesBanco Bank’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$27.2M Sell
29,595
-357
-1% -$362K 0.75% 30
2025
Q4
$32.2M Buy
29,952
+1,143
+4% +$1.09M 0.89% 18
2025
Q3
$22M Buy
28,809
+248
+0.9% +$185K 0.61% 40
2025
Q2
$22.3M Buy
28,561
+4,815
+20% +$3.74M 0.66% 35
2025
Q1
$19.6M Sell
23,746
-276
-1% -$230K 0.68% 35
2024
Q4
$18.5M Sell
24,022
-1,776
-7% -$1.47M 0.63% 37
2024
Q3
$22.9M Sell
25,798
-1,608
-6% -$1.45M 0.78% 30
2024
Q2
$24.8M Sell
27,406
-1,194
-4% -$955K 0.93% 20
2024
Q1
$22.2M Buy
28,600
+6,586
+30% +$4.69M 0.84% 23
2023
Q4
$12.8M Sell
22,014
-8,789
-29% -$5.13M 0.73% 36
2023
Q3
$16.5M Sell
30,803
-204
-0.7% -$105K 0.72% 28
2023
Q2
$14.5M Sell
31,007
-2,517
-8% -$1.06M 0.61% 38
2023
Q1
$11.5M Sell
33,524
-1,055
-3% -$356K 0.5% 55
2022
Q4
$12.7M Buy
34,579
+11,297
+49% +$4.01M 0.56% 49
2022
Q3
$7.53M Sell
23,282
-13,182
-36% -$4.18M 0.51% 56
2022
Q2
$11.8M Sell
36,464
-50
-0.1% -$15K 0.52% 53
2022
Q1
$10.5M Sell
36,514
-117
-0.3% -$30.1K 0.4% 72
2021
Q4
$10.1M Sell
36,631
-1,094
-3% -$277K 0.36% 74
2021
Q3
$8.72M Sell
37,725
-2,348
-6% -$580K 0.33% 76
2021
Q2
$9.2M Sell
40,073
-1,123
-3% -$226K 0.34% 75
2021
Q1
$7.7M Buy
+41,196
New +$8.06M 0.3% 85
2020
Q3
$6.13M Buy
41,441
+2,517
+6% +$390K 0.28% 95
2020
Q2
$6.39M Sell
38,924
-2,440
-6% -$375K 0.31% 87
2020
Q1
$5.74M Buy
41,364
+13,192
+47% +$1.81M 0.33% 80
2019
Q4
$3.7M Sell
28,172
-265
-0.9% -$30.7K 0.17% 132
2019
Q3
$3.18M Sell
28,437
-670
-2% -$74.6K 0.16% 128
2019
Q2
$3.22M Sell
29,107
-185
-0.6% -$21.8K 0.16% 130
2019
Q1
$3.8M Buy
29,292
+2,750
+10% +$334K 0.19% 115
2018
Q4
$3.07M Buy
26,542
+95
+0.4% +$10.6K 0.18% 115
2018
Q3
$2.84M Sell
26,447
-1,515
-5% -$151K 0.14% 141
2018
Q2
$2.39M Sell
27,962
-1,174
-4% -$96.4K 0.12% 163
2018
Q1
$2.25M Sell
29,136
-1,394
-5% -$112K 0.12% 167
2017
Q4
$2.58M Sell
30,530
-548
-2% -$46.6K 0.17% 119
2017
Q3
$2.66M Buy
31,078
+157
+0.5% +$12.9K 0.14% 145
2017
Q2
$2.54M Buy
30,921
+200
+0.7% +$16.3K 0.14% 139
2017
Q1
$2.58M Sell
30,721
-58
-0.2% -$4.65K 0.14% 137
2016
Q4
$2.26M Sell
30,779
-12,972
-30% -$966K 0.13% 147
2016
Q3
$3.51M Hold
43,751
0.21% 102
2016
Q2
$3.45M Sell
43,751
-2,875
-6% -$216K 0.21% 108
2016
Q1
$3.36M Buy
46,626
+601
+1% +$45.5K 0.2% 109
2015
Q4
$3.88M Sell
46,025
-3,066
-6% -$254K 0.23% 101
2015
Q3
$4.11M Buy
49,091
+2,140
+5% +$181K 0.25% 94
2015
Q2
$3.92M Buy
46,951
+140
+0.3% +$10.7K 0.22% 102
2015
Q1
$3.4M Buy
46,811
+9,717
+26% +$692K 0.19% 115
2014
Q4
$2.56M Buy
37,094
+1,520
+4% +$103K 0.14% 144
2014
Q3
$2.31M Buy
35,574
+1,372
+4% +$86.9K 0.13% 145
2014
Q2
$2.13M Buy
34,202
+434
+1% +$25.9K 0.12% 151
2014
Q1
$1.99M Sell
33,768
-340
-1% -$19K 0.11% 157
2013
Q4
$1.74M Sell
34,108
-14,206
-29% -$711K 0.1% 167
2013
Q3
$2.43M Buy
48,314
+3,450
+8% +$181K 0.15% 126
2013
Q2
$2.2M Buy
+44,864
New +$2.44M 0.14% 126

Other funds holding LLY

WesBanco Bank's LLY Position: Q1 2026 in Review

WesBanco Bank reduced its Eli Lilly (LLY) stake by 1.2% in Q1 2026, selling an estimated $362K and leaving 29,595 shares worth $27.2M. The position accounts for 0.75% of the portfolio, ranked #30.

WesBanco Bank first reported a position in LLY in Q2 2013 and has held it in 51 quarters since. The position peaked at $32.2M in Q4 2025. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • WesBanco Bank held 29,595 shares of Eli Lilly worth $27.2M as of Q1 2026.
  • WesBanco Bank sold 357 Eli Lilly shares in Q1 2026, an estimated $362K.
  • Eli Lilly made up 0.75% of WesBanco Bank's portfolio in Q1 2026, its #30 holding.
  • WesBanco Bank first reported a position in Eli Lilly in Q2 2013 and has held it in 51 quarters since.
  • WesBanco Bank's Eli Lilly position peaked at $32.2M in Q4 2025.
  • 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on WesBanco Bank's 13F filing for Q1 2026, filed 21 Apr 2026.